CDK Inhibitors : Cell Cycle Regulators and Beyond
暂无分享,去创建一个
James M. Roberts | Steven F Dowdy | A. Besson | S. Dowdy | Arnaud Besson | James M Roberts | Arnaud Besson | James M. Roberts
[1] Y. Yoneda,et al. 14‐3‐3 suppresses the nuclear localization of threonine 157‐phosphorylated p27Kip1 , 2004 .
[2] A. Hall,et al. Rho GTPases in cell biology , 2002, Nature.
[3] K. Münger,et al. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. , 1997, Genes & development.
[4] James M. Roberts,et al. IS023 Cleavage of p21^ and p27^ Mediates Apoptosis in Endothelial Cells Through Activation of Cdk2: Role of a Caspase-3-like Caspase Cascade , 1998 .
[5] A. Iavarone,et al. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. , 1995, Genes & development.
[6] C. Turck,et al. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit , 1993, Nature.
[7] T. Mukai,et al. Imprinting disruption of the CDKN1C/KCNQ1OT1 domain: the molecular mechanisms causing Beckwith-Wiedemann syndrome and cancer , 2006, Cytogenetic and Genome Research.
[8] Louise Izatt,et al. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. , 2007, The Journal of clinical endocrinology and metabolism.
[9] J. Slingerland,et al. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest , 2002, Nature Medicine.
[10] R. Bast,et al. Subcellular Localization of p 27 kip 1 Expression Predicts Poor Prognosis in Human Ovarian Cancer , 2005 .
[11] T. Tsuruo,et al. Phosphorylation of p27Kip1 at Threonine 198 by p90 Ribosomal Protein S6 Kinases Promotes Its Binding to 14-3-3 and Cytoplasmic Localization* , 2003, Journal of Biological Chemistry.
[12] J. Kench,et al. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. , 2001, Cancer research.
[13] O. Bachs,et al. Binding of Calmodulin to the Carboxy-Terminal Region of p21 Induces Nuclear Accumulation via Inhibition of Protein Kinase C-Mediated Phosphorylation of Ser153 , 2005, Molecular and Cellular Biology.
[14] E. Sahai,et al. ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. , 2003, Cancer cell.
[15] David Beach,et al. p21 is a universal inhibitor of cyclin kinases , 1993, Nature.
[16] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[17] Keiji Tanaka,et al. p57Kip2 Regulates Actin Dynamics by Binding and Translocating LIM-kinase 1 to the Nucleus* , 2003, Journal of Biological Chemistry.
[18] F. Gosselet,et al. BMP2 and BMP6 control p57(Kip2) expression and cell growth arrest/terminal differentiation in normal primary human epidermal keratinocytes. , 2007, Cellular signalling.
[19] M. Surani,et al. Cdkn1c (p57Kip2) is the major regulator of embryonic growth within its imprinted domain on mouse distal chromosome 7 , 2007, BMC Developmental Biology.
[20] O. Bachs,et al. The Protein SET Regulates the Inhibitory Effect of p21Cip1 on Cyclin E-Cyclin-dependent Kinase 2 Activity* , 1999, The Journal of Biological Chemistry.
[21] Pumin Zhang,et al. p57 and Hes1 coordinate cell cycle exit with self-renewal of pancreatic progenitors. , 2006, Developmental biology.
[22] O. Bachs,et al. The SET Protein Regulates G2/M Transition by Modulating Cyclin B-Cyclin-dependent Kinase 1 Activity* , 2003, The Journal of Biological Chemistry.
[23] M. Pagano,et al. Novel p27kip1 C-Terminal Scatter Domain Mediates Rac-Dependent Cell Migration Independent of Cell Cycle Arrest Functions , 2003, Molecular and Cellular Biology.
[24] K. Münger,et al. The human papillomavirus E 7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p 21 Cip 1-mediated inhibition of cdk 2 , 1997 .
[25] B. Vanhaesebroeck,et al. The p110delta isoform of PI 3-kinase negatively controls RhoA and PTEN. , 2007, The EMBO journal.
[26] H. Yoshikawa,et al. Cytoplasmic p21(Cip1/WAF1) enhances axonal regeneration and functional recovery after spinal cord injury in rats. , 2004, Neuroscience.
[27] M. Hoshino,et al. Cdk5 phosphorylates and stabilizes p27kip1 contributing to actin organization and cortical neuronal migration , 2006, Nature Cell Biology.
[28] B. Joseph,et al. The cell cycle inhibitor p57Kip2 promotes cell death via the mitochondrial apoptotic pathway , 2007, Cell Death and Differentiation.
[29] P. Leder,et al. Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[30] Y. Fukushima,et al. New p57KIP2 mutations in Beckwith-Wiedemann syndrome , 1997, Human Genetics.
[31] Y. Yoneda,et al. 14-3-3 suppresses the nuclear localization of threonine 157-phosphorylated p27(Kip1). , 2004, The EMBO journal.
[32] M. Lisanti,et al. Cyclin D1 induction of cellular migration requires p27(KIP1). , 2006, Cancer research.
[33] T. Mukai,et al. Functional analysis of the p57KIP2 gene mutation in Beckwith-Wiedemann syndrome , 1999, Human Genetics.
[34] K. Nakayama,et al. The Cyclin-dependent Kinase Inhibitors p57 and p27 Regulate Neuronal Migration in the Developing Mouse Neocortex* , 2007, Journal of Biological Chemistry.
[35] M. Pagano,et al. Regulation of the Cdk inhibitor p27 and its deregulation in cancer , 2000, Journal of cellular physiology.
[36] J. Massagué,et al. p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. , 1995, Cancer research.
[37] 近藤 征史. Selective maternal-allele loss in human lung cancers of the maternally expressed p57[KIP2] gene at 11p15.5 , 1998 .
[38] C. Marshall,et al. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1 , 1998, Nature.
[39] Tony Hunter,et al. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 , 1994, Cell.
[40] James M. Roberts,et al. The murine gene p27Kip1 is haplo-insufficient for tumour suppression , 1998, Nature.
[41] 田中 啓之. Cytoplasmic p21Cip1/WAF1 regulates neurite remodeling by inhibiting Rho-kinase activity , 2005 .
[42] M. Barbacid,et al. Genetic Analysis of Mammalian Cyclin-Dependent Kinases and Their Inhibitors , 2000, Biological chemistry.
[43] Vikram Devgan,et al. p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. , 2005, Genes & development.
[44] A. Feinberg,et al. Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome. , 1997, American journal of human genetics.
[45] S. Elledge,et al. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. , 1995, Genes & development.
[46] M. Serrano,et al. Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. , 2001, Cancer research.
[47] C. Cordon-Cardo,et al. Somatic cell type specific gene transfer reveals a tumor-promoting function for p21Waf1/Cip1 , 2007, The EMBO journal.
[48] Stanley N Cohen,et al. Negative regulation of cell growth and differentiation by TSG101 through association with p21Cip1/WAF1 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[49] R. Kerbel,et al. Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents , 1996, Nature Medicine.
[50] S. Blain,et al. Differential Modification of p27Kip1 Controls Its Cyclin D-cdk4 Inhibitory Activity , 2007, Molecular and Cellular Biology.
[51] N. Perkins,et al. A Novel Transcriptional Repression Domain Mediates p21WAF1/CIP1 Induction of p300 Transactivation , 2000, Molecular and Cellular Biology.
[52] J. Massagué,et al. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. , 1995, Genes & development.
[53] A. Koff,et al. Rho Activity Can Alter the Translation of p27 mRNA and Is Important for RasV12-induced Transformation in a Manner Dependent on p27 Status* , 2002, The Journal of Biological Chemistry.
[54] H. Yoshikawa,et al. Cytoplasmic p21Cip1/WAF1 enhances axonal regeneration and functional recovery after spinal cord injury in rats , 2004, Neuroscience.
[55] J. Priess,et al. Cell polarity and gastrulation in C. elegans. , 2002, Development.
[56] A. Gillenwater,et al. Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2 gene in head and neck squamous cell carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[57] James M. Roberts,et al. Discovery of an oncogenic activity in p27Kip1 that causes stem cell expansion and a multiple tumor phenotype. , 2007, Genes & development.
[58] Stephen J. Elledge,et al. Mice Lacking p21 CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control , 1995, Cell.
[59] M. Miura,et al. Resistance to Fas-mediated apoptosis: activation of Caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP , 1998, Oncogene.
[60] M. Serrano,et al. Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice , 2004, Oncogene.
[61] G. Borisy,et al. Cell Migration: Integrating Signals from Front to Back , 2003, Science.
[62] L. Di Marcotullio,et al. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis , 2001, The EMBO journal.
[63] James M. Roberts,et al. Requirement of p27Kip1 for Restriction Point Control of the Fibroblast Cell Cycle , 1996, Science.
[64] K. Nakayama,et al. p57KIP2 Modulates Stress-activated Signaling by Inhibiting c-Jun NH2-terminal Kinase/Stress-activated Protein Kinase* , 2003, Journal of Biological Chemistry.
[65] J. Baldassare,et al. RhoA Stimulates p27Kip Degradation through Its Regulation of Cyclin E/CDK2 Activity* , 1999, The Journal of Biological Chemistry.
[66] R. Bast,et al. Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[67] Nobuyuki Shishido,et al. Mice Lacking p27 Kip1 Display Increased Body Size, Multiple Organ Hyperplasia, Retinal Dysplasia, and Pituitary Tumors , 1996, Cell.
[68] L. Hengst,et al. p27 Phosphorylation by Src Regulates Inhibition of Cyclin E-Cdk2 , 2007, Cell.
[69] H. Gascan,et al. Functional Interaction of STAT3 Transcription Factor with the Cell Cycle Inhibitor p21 WAF1/CIP1/SDI1 * , 2000, The Journal of Biological Chemistry.
[70] A. Philpott,et al. The cdk inhibitor p27Xic1 is required for differentiation of primary neurones in Xenopus , 2003, Development.
[71] James M. Roberts,et al. CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.
[72] I. Roninson,et al. Tumor cell senescence in cancer treatment. , 2003, Cancer research.
[73] L. Hengst,et al. CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nuclear export signal and links p27 export and proteolysis. , 2003, Molecular biology of the cell.
[74] M. Leibovitch,et al. Stabilization of MyoD by Direct Binding to p57Kip2 * , 2000, The Journal of Biological Chemistry.
[75] H. Yoshikawa,et al. Cytoplasmic p21Cip1/WAF1 regulates neurite remodeling by inhibiting Rho-kinase activity , 2002, The Journal of cell biology.
[76] Natalie A. Lissy,et al. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration , 1998, Nature Medicine.
[77] J. Diehl,et al. p21Cip1 Promotes Cyclin D1 Nuclear Accumulation via Direct Inhibition of Nuclear Export* , 2002, The Journal of Biological Chemistry.
[78] W. El-Deiry,et al. Phosphorylation of p21 in G2/M Promotes Cyclin B-Cdc2 Kinase Activity , 2005, Molecular and Cellular Biology.
[79] L. Hengst,et al. p27 binds cyclin–CDK complexes through a sequential mechanism involving binding-induced protein folding , 2004, Nature Structural &Molecular Biology.
[80] M. Serrano,et al. Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma , 2006, Oncogene.
[81] I. Roninson. Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. , 2002, Cancer letters.
[82] B. Tycko,et al. Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors. , 1997, American journal of human genetics.
[83] T. Lyngbye,et al. [Beckwith-Wiedemann syndrome]. , 1985, Ugeskrift for laeger.
[84] H. Yoshikawa,et al. Reciprocal Regulation via Protein-Protein Interaction between c-Myc and p21 cip1/waf1/sdi1 in DNA Replication and Transcription* , 2000, The Journal of Biological Chemistry.
[85] Paul Martin,et al. Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.
[86] E. Nabel,et al. The cell cycle regulator p27Kip1 interacts with MCM7, a DNA replication licensing factor, to inhibit initiation of DNA replication , 2005, FEBS letters.
[87] James M. Roberts,et al. [p27Kip1 independently promotes neuronal differentiation and migration in the cerebral cortex]. , 2006, Bulletin et memoires de l'Academie royale de medecine de Belgique.
[88] I. Herskowitz,et al. The role of Far1p in linking the heterotrimeric G protein to polarity establishment proteins during yeast mating. , 1998, Science.
[89] C. Cordon-Cardo,et al. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[90] James M. Roberts,et al. Regulation of the cytoskeleton: an oncogenic function for cdk inhibitors? , 2004, Nature Reviews Cancer.
[91] Alan Hall,et al. Rho GTPases Control Polarity, Protrusion, and Adhesion during Cell Movement , 1999, The Journal of cell biology.
[92] K. Manova-Todorova,et al. Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27 Kip1 , 1996, Cell.
[93] James M. Roberts,et al. Cloning of p27 Kip1 , a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals , 1994, Cell.
[94] Frederick Y. Wu,et al. Reduction of cytosolic p27(Kip1) inhibits cancer cell motility, survival, and tumorigenicity. , 2006, Cancer research.
[95] D. Mann,et al. The Intricacies of p21 Phosphorylation: Protein/Protein Interactions, Subcellular Localization and Stability , 2006, Cell cycle.
[96] R. Bronson,et al. Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[97] A. Feinberg,et al. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[98] D. Cheresh,et al. Bifurcation of Cell Migratory and Proliferative Signaling by the Adaptor Protein Shc , 1999, The Journal of cell biology.
[99] P. Pandolfi,et al. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse , 2001, Nature Genetics.
[100] S. Iguchi-Ariga,et al. TOK-1, a Novel p21Cip1-binding Protein That Cooperatively Enhances p21-dependent Inhibitory Activity toward CDK2 Kinase* , 2000, The Journal of Biological Chemistry.
[101] P. Soloway,et al. Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1 , 2002, Nature Genetics.
[102] B. Vanhaesebroeck,et al. The p110δ isoform of PI 3‐kinase negatively controls RhoA and PTEN , 2007 .
[103] M. Frey,et al. Epidermal Growth Factor-stimulated Intestinal Epithelial Cell Migration Requires Src Family Kinase-dependent p38 MAPK Signaling* , 2004, Journal of Biological Chemistry.
[104] James M. Roberts,et al. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. , 1994, Genes & development.
[105] Keith Burridge,et al. RhoA is required for monocyte tail retraction during transendothelial migration , 2001, The Journal of cell biology.
[106] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[107] Erik Sahai,et al. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis , 2003, Nature Cell Biology.
[108] Philip D. Jeffrey,et al. Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex , 1996, Nature.
[109] A. Sewing,et al. Cyclins D1 and D2 mediate Myc‐induced proliferation via sequestration of p27Kip1 and p21Cip1 , 1999, The EMBO journal.
[110] James M. Roberts,et al. p27Kip1 modulates cell migration through the regulation of RhoA activation. , 2004, Genes & development.
[111] B. Stillman,et al. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. , 1997, Genes & development.
[112] K. Welte,et al. Tyrosine phosphorylation modulates binding preference to cyclin-dependent kinases and subcellular localization of p27Kip1 in the acute promyelocytic leukemia cell line NB4. , 2006, Blood.
[113] Yong Lin,et al. A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[114] E. Pérez-Payá,et al. The Structural Plasticity of the C Terminus of p21Cip1 is a Determinant for Target Protein Recognition , 2003, Chembiochem : a European journal of chemical biology.
[115] M. Hung,et al. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells , 2001, Nature Cell Biology.
[116] James M. Roberts,et al. A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 Kip1 -Deficient Mice , 1996, Cell.
[117] A. Lenferink,et al. ErbB2/Neu-Induced, Cyclin D1-Dependent Transformation Is Accelerated in p27-Haploinsufficient Mammary Epithelial Cells but Impaired in p27-Null Cells , 2002, Molecular and Cellular Biology.
[118] R. DePinho,et al. Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[119] James M. Roberts,et al. The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury , 1998, Nature Medicine.
[120] C. Cordon-Cardo,et al. p27 as a target for cancer therapeutics. , 2003, Cancer cell.
[121] M. Toyota,et al. Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors , 2002, Oncogene.
[122] E. Brambilla,et al. The yin and the yang of p27Kip1 as a target for cancer therapy , 2004, European Respiratory Journal.
[123] James M. Roberts,et al. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. , 2006, Genes & development.
[124] H. Höfler,et al. Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans , 2006, Proceedings of the National Academy of Sciences.
[125] R. Maione,et al. p57Kip2 is induced by MyoD through a p73-dependent pathway. , 2006, Journal of molecular biology.
[126] J. LaBaer,et al. New functional activities for the p21 family of CDK inhibitors. , 1997, Genes & development.
[127] C. Stewart,et al. Induction of p57KIP2 expression by p73β , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[128] S. Elledge,et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndrome , 1997, Nature.
[129] Giovanni Vanni Frajese,et al. miR-221 and miR-222 Expression Affects the Proliferation Potential of Human Prostate Carcinoma Cell Lines by Targeting p27Kip1* , 2007, Journal of Biological Chemistry.
[130] F. Ragione,et al. p27Kip1 Metabolism: A Fascinating Labyrinth , 2007, Cell cycle.
[131] J. Adkins,et al. Intrinsic structural disorder and sequence features of the cell cycle inhibitor p57Kip2 , 2002, Proteins.
[132] J. Massagué,et al. Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1 , 1995, Nature.
[133] E. Choi,et al. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases , 1996, Nature.
[134] L. Delavaine,et al. Control of E2F activity by p21Waf1/Cip1 , 1999, Oncogene.
[135] D. Helfman,et al. Cytoplasmic p21Cip1 Is Involved in Ras-induced Inhibition of the ROCK/LIMK/Cofilin Pathway* , 2004, Journal of Biological Chemistry.
[136] A. Gartel,et al. Transcriptional regulation of the p21((WAF1/CIP1)) gene. , 1999, Experimental cell research.
[137] M. Schwartz,et al. Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. , 2000, Journal of cell science.
[138] V. Godfrey,et al. Functional Collaboration between Different Cyclin-Dependent Kinase Inhibitors Suppresses Tumor Growth with Distinct Tissue Specificity , 2000, Molecular and Cellular Biology.
[139] S. Elledge,et al. Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5. , 1996, Oncogene.
[140] S. Toyooka,et al. Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas. , 2004, Oncology reports.
[141] E. Sahai,et al. Cross‐talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility , 2001, The EMBO journal.
[142] R. Perris. The extracellular matrix in neural crest-cell migration , 1997, Trends in Neurosciences.
[143] Reuven Agami,et al. Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation , 2007 .
[144] M. Roussel,et al. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[145] M. Barbacid,et al. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. , 1997, Genes & development.
[146] Shile Huang,et al. Sustained activation of the JNK cascade and rapamycin-induced apoptosis are suppressed by p53/p21(Cip1). , 2003, Molecular cell.
[147] Chen-feng Qi,et al. Expression of the cyclin-dependent kinase inhibitor p27 and its deregulation in mouse B cell lymphomas. , 2006, Leukemia research.
[148] B. Datnow,et al. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma. , 2007, Cancer research.
[149] Richard W. Kriwacki,et al. Cdk-Inhibitory Activity and Stability of p27 Kip1 Are Directly Regulated by Oncogenic Tyrosine Kinases , 2007, Cell.
[150] Matthias Peter,et al. Nuclear sequestration of the exchange factor Cdc24 by Far1 regulates cell polarity during yeast mating , 2000, Nature Cell Biology.